2Savcic M,Hauert J,Bachmann F,et al.Clopidogrel loading dose regimens:kinetic profile of pharmacodynamic response in healthy subject[J].Semin Thromb Hemost,1999,25(suppl 2):15-19.
3Gawaz M,Neumann FJ,Ott I,et al.Platelet activation and stent implantation.Effect of antithrombotic therapy[J].Circulation,1996,94(3):279-285.
4Mehta SR,Yusuf S,Peters RJ,et al.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCI-CURE study[J].Lancet,2001,358(9281):527-533.
5Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J].N Engl J Med,2001,345(7):494-502.
6Steinhubl SR,Berger PB,Mann JT 3rd,et al.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial[J].JAMA,2002,288(19):2411-2420.
7Ahmed JM,Mintz GS,Waksman R,et al.Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions[J].Am J Cardiol,2001,87(10):1145-1149.
8Ahmed JM,Mintz GS,Waksman R,et al.Serial intravascular ultrasound assessment of the efficacy of intracoronary gamma-radiation therapy for preventing recurrence in very long,diffuse,in-stent restenosis lesions[J].Circulation,2001,104(8):856-859.
9Waksman R,Ajani AE,Pinnow E,et al.Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis:Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS[J].Circulation,2002,106(7):776-778.
10Schwartz RS,Edelman ER,Carter A,et al.Drug-eluting stents in preclinical studies:recommended evaluation from a consensus group[J].Circulation,2002,106(14):1867-1873.
4Muller I, Besta F, Schulz C, et al. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement[J]. Thromb Haemost, 2003, 89 ( 5 ) : 783 - 787.
5Gurbel P A, Bliden K P, Hiatt B L, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity[ J ]. Circulation, 2003, 107 (23) : 2908 - 2913.
6Wang Z J, Zhou Y J, Liu Y Y, et al. Impact of clopidogrel resistance on thrombotic events after pcrcutaneous coronary intervention with drugeluting stent[J]. Thromb Res, 2009, 124( 1 ) : 46 -51.
7Azar A J, Cannegieter S C, Deckers J W, et al. Optimal intensity of oral anticoagulant therapy after myocardial infarction [ J ]. J Am Coll Cardiol, 1996, 27(6): 1349-1355.
8Barragan P, Bouvier J L, Roquebert P O, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation[J]. Cather Cardiovasc Interv, 2003, 59(3): 295- 302.
9Wiviott S D, Antman E M. Clopidogrel resistance: a new chapter in a fast-moving story [ J ]. Circulation, 2004, 109 (25) : 3064 - 3067.
10Nguyen T A, Diodati J G, Pharand C. Resistance to clopidogrel: a review of the evidence[J].J Am Coll Cardiol, 2005, 45 (8) : 1157 -1164.
